350 related articles for article (PubMed ID: 10897066)
21. [Suppression effects of interleukin-10 on mouse herpetic stromal keratitis].
Xia LK; Gao DW; Pu W; Zhang JS
Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):592-6. PubMed ID: 14766072
[TBL] [Abstract][Full Text] [Related]
22. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages.
Bauer D; Mrzyk S; Van Rooijen N; Steuhl KP; Heiligenhaus A
Exp Eye Res; 2001 Mar; 72(3):261-9. PubMed ID: 11180975
[TBL] [Abstract][Full Text] [Related]
23. Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye.
Valyi-Nagy T; Sheth V; Clement C; Tiwari V; Scanlan P; Kavouras JH; Leach L; Guzman-Hartman G; Dermody TS; Shukla D
Curr Eye Res; 2004; 29(4-5):303-9. PubMed ID: 15590476
[TBL] [Abstract][Full Text] [Related]
24. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
[TBL] [Abstract][Full Text] [Related]
25. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.
Heiligenhaus A; Bauer D; Meller D; Steuhl KP; Tseng SC
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1969-74. PubMed ID: 11481259
[TBL] [Abstract][Full Text] [Related]
26. Staining characteristics and antiviral activity of sulforhodamine B and lissamine green B.
Chodosh J; Dix RD; Howell RC; Stroop WG; Tseng SC
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1046-58. PubMed ID: 7510270
[TBL] [Abstract][Full Text] [Related]
27. [Cytokine expression in murine cornea tissue during recurrent herpetic stromal keratitis].
Xia LK; Zhang JS; Chen XL; Wang AY
Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):403-8. PubMed ID: 15938803
[TBL] [Abstract][Full Text] [Related]
28. The survival of herpes simplex virus in preserved murine corneas.
Robert PY; Ducher V; Pleyer U; Denis F; Adenis JP; Ranger-Rogez S
Ophthalmic Res; 2008 Oct; 40(6):329-32. PubMed ID: 18698148
[TBL] [Abstract][Full Text] [Related]
29. Application of FGF-2 to modulate herpetic stromal keratitis.
Kim B; Lee S; Kaistha SD; Rouse BT
Curr Eye Res; 2006 Dec; 31(12):1021-8. PubMed ID: 17169840
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo antiherpetic activity of three new synthetic brassinosteroid analogues.
Michelini FM; RamÃrez JA; Berra A; Galagovsky LR; Alché LE
Steroids; 2004; 69(11-12):713-20. PubMed ID: 15579323
[TBL] [Abstract][Full Text] [Related]
31. The severity of herpes simplex viral keratitis in mice does not reflect the severity of disease in humans.
Rinne JR; Abghari SZ; Stulting RD
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):268-72. PubMed ID: 1310955
[TBL] [Abstract][Full Text] [Related]
32. Treatment of mice with anti-CD86 mAb reduces CD8+ T cell-mediated CTL activity and enhances ocular viral replication in HSV-1-infected mice.
Osorio Y; Cai S; Ghiasi H
Ocul Immunol Inflamm; 2005; 13(2-3):159-67. PubMed ID: 16019675
[TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
[TBL] [Abstract][Full Text] [Related]
34. [Herpes simplex virus type 1 in the samples of patients with clinically prediagnosed as herpetic keratitis or keratoconjunctivitis].
Biriken D; Yildiz S; Ozkul A; Ozsan M
Mikrobiyol Bul; 2004; 38(1-2):51-9. PubMed ID: 15293902
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model.
Bhattacharjee PS; Neumann DM; Stark D; Thompson HW; Hill JM
Curr Eye Res; 2006 Sep; 31(9):703-8. PubMed ID: 16966142
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of Indonesian medicinal plants on the infection of herpes simplex virus type 1.
Nawawi A; Nakamura N; Hattori M; Kurokawa M; Shiraki K
Phytother Res; 1999 Feb; 13(1):37-41. PubMed ID: 10189948
[TBL] [Abstract][Full Text] [Related]
37. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis.
Remeijer L; Maertzdorf J; Buitenwerf J; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):358-63. PubMed ID: 11818377
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
Frye TD; Chiou HC; Hull BE; Bigley NJ
Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
[TBL] [Abstract][Full Text] [Related]
39. Effect of oral valaciclovir on herpetic keratitis.
Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
[TBL] [Abstract][Full Text] [Related]
40. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
Hendricks RL; Tumpey TM
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
